The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
30
No.
21
May 21, 2004May 21, 2004
Free
DOWNLOAD THE PDF

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize.

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

In Brief: ASCO awards career development grants.

Funding Opportunities listed.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account